Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Green & Schafle Partner David Carney obtains $500k award for client who suffered GBS after a flu vaccine


News provided by

Green & Schafle

May 13, 2024, 07:30 ET

Share this article

Share toX

Share this article

Share toX

Our vaccine trial lawyer, David Carney, obtained a substantial award for his client who suffered from Guillain-Barre Syndrome (GBS) after receiving the influenza vaccine. The award of $575,000 covers his client's pain and suffering, future lost wages and future medical care for the rest of his life. The award comes after much litigation about whether the flu shot caused his client's GBS and the size and scope of the damages he was entitled to.

PHILADELPHIA, May 13, 2024 /PRNewswire-PRWeb/ -- David Carney's client, a 76-year old military veteran from San Antonio, Texas, received his flu vaccine on October 3, 2018 and within a few weeks, developed a sudden and rapid onset of numbness, tingling and weakness in his lower extremities rendering him unable to walk independently. He was rushed to San Antonio Military Medical Center for workup and after a spinal tap, he was admitted for diagnosis and treatment of his Guillain-Barre Syndrome. His post-hospital course consisted of inpatient rehabilitation for several weeks followed by inpatient admission at a skilled nursing facility for several months. After discharge from skilled nursing, he was enrolled in outpatient physical and occupational therapy and home health services for the ongoing dysfunction related to his GBS.

Complex Damages Awarded After Expert Testimony

All vaccine injury cases must be filed in the National Vaccine Injury Compensation Program (VICP) through the U.S. Court of Federal Claims in Washington, D.C. All vaccine claims are defended by Department of Health and Human Services, through its attorneys at the U.S. Department of Justice.

The VICP has recognized that the influenza vaccine (flu shot) is presumed to cause GBS if the onset of GBS occurs between 3 and 42 days after the influenza vaccine. However, this case consisted of protracted litigation due the DOJ's defense of all items of compensation and damages. The DOJ attempted to marginalize Mr. Carney's client's pain and suffering, lost wages, and future medical care needs.

In the National Vaccine Injury Compensation Program, there exists a statutory pain and suffering cap of $250,000, which is the most one can receive for pain and suffering, and all medical care items must be offset by health insurance plans and any applicable disability plans.

Through multiple motions, oral arguments and damages hearings, Mr. Carney's zealous and persistent advocacy was able to get his client 75% of the statutory pain and suffering cap of $250,000. In addition, he was able to obtain past lost wages and future lost wages for an individual who was well past the retirement age since he continued to work part-time as a psychologist at the time of his injury. Finally, Mr. Carney obtained many vital elements of a life care plan that will ensure his client gets the services and medical assistance necessary to navigate and cope with his GBS, such as home and bathroom modifications, home health aide services, and assistive mobility devices. Mr. Carney was only able to do this by retaining highly qualified nursing expert to create a comprehensive life care plan and then testify in detail at a damages hearing on the elements of the plan.

The Importance of Retaining Experienced Trial Lawyers to Represent Your Vaccine Injury Case

In the current climate, the Department of Health and Human Services, or its attorneys at the U.S. Department of Justice are creating barriers at every level of the case in order to delay resolution of cases and suppress damages in viable cases. Green & Schafle vaccine lawyer, David Carney, has seen this change occur over the last 5-7 years. "About ten years ago, we would be able to resolve this case quickly and efficiently for roughly the same outcome, but over the last 5-7 years, and especially after the COVID-19 pandemic, we've had to scratch and claw for every dollar our clients deserve," Carney said. As such, it is critical to retain qualified and experienced vaccine injury lawyers who are trial lawyers and possess the skill, tenacity and resources to fight for you to the very end. Trial lawyers possess the key trial advocacy skills to diagnosis potential issues in your case, obtain the necessary medical experts to support the case, and to litigate the issues to resolution when faced with either frivolous causation arguments or lowball settlement offers.

Green & Schafle Law Firm of Philadelphia, PA

Green & Schafle specializes in serious personal injury cases, including vaccine injury litigation and mass tort/asbestos litigation. The firm, based out of Philadelphia, PA, has successfully litigated and resolved numerous high-profile personal injury matters and mass tort cases in recent years, including several that have garnered the attention of national news media. In addition, the vaccine lawyers at Green & Schafle law firm are uniquely licensed to help with vaccine injury cases nationwide.

Media Contact

David Carney, Green & Schafle, 1 (215) 462 3330, [email protected], https://www.greenlegalteam.com/

SOURCE Green & Schafle

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.